Research suggests that Grifola frondosa (maitake) may support weight-related metabolic outcomes, with studies pointing to potential benefits in lipid regulation, insulin resistance, and dietary energy intake. The available evidence comes primarily from animal models and review articles, including studies showing reduced hepatic triglycerides and cholesterol in a rat model of fatty liver disease, improved blood sugar control and reduced liver inflammation in a diabetic rat model, and observations that insoluble dietary fibers from maitake may influence energy intake. A 1996 review and a 2021 review both identify lipid-lowering effects as a notable property of this mushroom. However, it is important to note that the current body of evidence is largely preclinical, relying on animal and cell-based research rather than human clinical trials, which means the applicability of these findings to human weight management remains uncertain and warrants further investigation.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| [Experimental study on intervention effect of Grifola frondosa on nonalcoholi... | Other | 2015 | Supports | 68 |
| Herbal therapy as a promising approach for regulation on lipid profiles: A re... | Review | 2021 | Supports | 65 |
| Grifola frondosa Polysaccharide Ameliorates Inflammation by Regulating Macrop... | Other | 2024 | Supports | 62 |
| Functional properties of edible mushrooms. | Review | 1996 | Supports | 60 |
| Insoluble Dietary Fibers From By-Products of Edible Fungi Industry: Basic Str... | Other | 2022 | Supports | 58 |